Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database.

Cohen Aubart F, Lhote R, Amoura A, Valeyre D, Haroche J, Amoura Z, Lebrun-Vignes B.

J Intern Med. 2019 Oct 15. doi: 10.1111/joim.12991. [Epub ahead of print]

PMID:
31612562
2.

Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse.

Mathian A, Mouries-Martin S, Dorgham K, Devilliers H, Yssel H, Garrido Castillo L, Cohen-Aubart F, Haroche J, Hié M, Pineton de Chambrun M, Miyara M, Pha M, Rozenberg F, Gorochov G, Amoura Z.

Ann Rheum Dis. 2019 Sep 30. pii: annrheumdis-2019-215571. doi: 10.1136/annrheumdis-2019-215571. [Epub ahead of print]

PMID:
31570366
3.

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.

Donadieu J, Larabi IA, Tardieu M, Visser J, Hutter C, Sieni E, Kabbara N, Barkaoui M, Miron J, Chalard F, Milne P, Haroche J, Cohen F, Hélias-Rodzewicz Z, Simon N, Jehanne M, Kolenova A, Pagnier A, Aladjidi N, Schneider P, Plat G, Lutun A, Sonntagbauer A, Lehrnbecher T, Ferster A, Efremova V, Ahlmann M, Blanc L, Nicholson J, Lambilliote A, Boudiaf H, Lissat A, Svojgr K, Bernard F, Elitzur S, Golan M, Evseev D, Maschan M, Idbaih A, Slater O, Minkov M, Taly V, Collin M, Alvarez JC, Emile JF, Héritier S.

J Clin Oncol. 2019 Sep 12:JCO1900456. doi: 10.1200/JCO.19.00456. [Epub ahead of print]

PMID:
31513482
4.

Characterization of Interstitial Lung Disease Associated With Anti-Ribonucleoprotein Antibodies.

Lhote R, Grenier P, Haroche J, Miyara M, Boussouar S, Mathian A, Pha M, Amoura Z, Cohen Aubart F.

J Clin Rheumatol. 2019 Aug 13. doi: 10.1097/RHU.0000000000001127. [Epub ahead of print]

PMID:
31415476
5.

Response to trametinib of histiocytosis with an activating PTPN11 mutation.

Farnault L, Hélias-Rodzewicz Z, Venton G, Fanciullino R, Gabriel S, Mescam L, Haroche J, Donadieu J, Emile JF.

Leuk Lymphoma. 2019 Aug 8:1-4. doi: 10.1080/10428194.2019.1650175. [Epub ahead of print] No abstract available.

PMID:
31393194
6.

Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter.

Sbeih N, Mathian A, Pineton de Chambrun M, Lhote R, Zahr N, Pha M, Cohen-Aubart F, Haroche J, Hié M, Jouffroy S, Benameur N, Devilliers H, Amoura Z.

Ann Rheum Dis. 2019 Jul 8. pii: annrheumdis-2019-215732. doi: 10.1136/annrheumdis-2019-215732. [Epub ahead of print] No abstract available.

PMID:
31285257
7.

Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans Cell Histiocytosis.

Sagna Y, Courtillot C, Drabo JY, Tazi A, Donadieu J, Idbaih A, Cohen F, Amoura Z, Haroche J, Touraine P.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0177.R2. doi: 10.1530/EJE-19-0177. [Epub ahead of print]

PMID:
31269469
8.

Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation.

Bonnet P, Chasset F, Moguelet P, Abisror N, Itzykson R, Bouaziz JD, Hirsch P, Barbaud A, Haroche J, Mekinian A, Hélias-Rodzewicz Z, Clappier E, Fenaux P, Fain O, Tazi A, Emile JF; EMSED and MINHEMON.

Haematologica. 2019 Jun 20. pii: haematol.2019.223552. doi: 10.3324/haematol.2019.223552. [Epub ahead of print]

9.

Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.

Nielly H, Mathian A, Cazenave M, Izzedine H, Haroche J, Cohen-Aubart F, Hie M, Miyara M, Pineton de Chambrun M, Benameur N, Hausfater P, Pha M, Boutin-Lê Thi Huong D, Rouvier P, Brocheriou I, Cluzel P, Amoura Z.

Nephrol Dial Transplant. 2019 Jun 3. pii: gfz085. doi: 10.1093/ndt/gfz085. [Epub ahead of print]

PMID:
31157889
10.

Erdheim-Chester Disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1.

Razanamahery J, Diamond EL, Cohen-Aubart F, Plate KH, Lourida G, Charlotte F, Hélias-Rodzewicz Z, Goyal G, Go RS, Dogan A, Abdel-Wahab O, Durham B, Ozkaya N, Amoura Z, Emile JF, Haroche J.

Haematologica. 2019 May 23. pii: haematol.2019.216937. doi: 10.3324/haematol.2019.216937. [Epub ahead of print]

11.

Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J.

Curr Oncol Rep. 2019 May 21;21(7):62. doi: 10.1007/s11912-019-0810-6. Review.

PMID:
31115724
12.

The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.

Chazal T, Costopoulos M, Maillart E, Fleury C, Psimaras D, Legendre P, Pineton de Chambrun M, Haroche J, Lubetzki C, Amoura Z, Legarff-Tavernier M, Cohen Aubart F.

Eur J Neurol. 2019 Oct;26(10):1274-1280. doi: 10.1111/ene.13975. Epub 2019 Jun 24.

PMID:
31021023
13.

Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim-Chester patients.

Amoura A, Haroche J, Emile JF, Barete S, Helias-Rodzewicz Z, Charlotte F, Maisonobe T, Amoura Z, Cohen Aubart F.

J Eur Acad Dermatol Venereol. 2019 Oct;33(10):e348-e350. doi: 10.1111/jdv.15636. Epub 2019 May 14. No abstract available.

PMID:
31002424
14.

Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors.

Roeser A, Cohen-Aubart F, Breillat P, Miyara M, Emile JF, Charlotte F, Donadieu J, Amoura Z, Haroche J.

Haematologica. 2019 Mar 28. pii: haematol.2018.214007. doi: 10.3324/haematol.2018.214007. [Epub ahead of print]

15.

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.

Riller Q, Cotteret C, Junot H, Benameur N, Haroche J, Mathian A, Hie M, Miyara M, Tilleul P, Amoura Z, Cohen Aubart F.

J Neurol. 2019 May;266(5):1073-1078. doi: 10.1007/s00415-019-09234-y. Epub 2019 Feb 9.

PMID:
30739183
16.

Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich's syndrome): frequency, clinical implication and prognosis.

Abisror N, Mekinian A, Dechartres A, Groh M, Berezne A, Noel N, Morati C, Haroche J, Hunault-Berger M, Agard C, Ackermann F, Geffray L, Jeandel PY, Trouillier S, Quemeneur T, Dufour JF, Lamaury I, Lhote F, Lefèvre G, Fain O, Kahn JE; French Eosinophil Network.

J Am Acad Dermatol. 2019 Feb 6. pii: S0190-9622(19)30196-3. doi: 10.1016/j.jaad.2019.02.001. [Epub ahead of print]

PMID:
30738125
17.

Long-bones involvement in generalized crystal-storing histiocytosis.

Michon A, Cohen Aubart F, Haroche J, Charlotte F, Maksud P, Amoura Z.

Joint Bone Spine. 2019 Oct;86(5):652-653. doi: 10.1016/j.jbspin.2019.01.006. Epub 2019 Jan 25. No abstract available.

PMID:
30685538
18.

Glomeruloid haemangioma: a possible consequence of elevated VEGF in POEMS and Erdheim-Chester disease.

Legendre P, Norkowski E, Le Pelletier F, Miyara M, Choquet S, Haroche J, Brocheriou I, Barete S.

Eur J Dermatol. 2018 Dec 1;28(6):784-789. doi: 10.1684/ejd.2018.3451.

PMID:
30563806
19.

Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.

Mathian A, Mouries-Martin S, Dorgham K, Devilliers H, Barnabei L, Ben Salah E, Cohen-Aubart F, Garrido Castillo L, Haroche J, Hie M, Pineton de Chambrun M, Miyara M, Sterlin D, Pha M, Lê Thi Huong D, Rieux-Laucat F, Rozenberg F, Gorochov G, Amoura Z.

Arthritis Rheumatol. 2019 May;71(5):756-765. doi: 10.1002/art.40792.

PMID:
30507062
20.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.

Héritier S, Barkaoui MA, Miron J, Thomas C, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Jeziorski E, Plat G, Aladjidi N, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Pagnier A, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Gandemer V, Martin-Duverneuil N, Taly V, Hélias-Rodzewicz Z, Emile JF, Hoang-Xuan K, Idbaih A, Donadieu J.

Br J Haematol. 2018 Nov;183(4):608-617. doi: 10.1111/bjh.15577. Epub 2018 Nov 12.

PMID:
30421536
21.

Giant-cell arteritis-related mortality in France: A multiple-cause-of-death analysis.

Chazal T, Lhote R, Rey G, Haroche J, Eb M, Amoura Z, Cohen Aubart F.

Autoimmun Rev. 2018 Dec;17(12):1219-1224. doi: 10.1016/j.autrev.2018.06.012. Epub 2018 Oct 11. Review.

22.

Highly sensitive methods are required to detect mutations in histiocytoses.

Melloul S, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Fraitag S, Terrones N, Riller Q, Chazal T, Héritier S, Moreau A, Kambouchner M, Copin MC, Donadieu J, Taly V, Amoura Z, Haroche J, Emile JF.

Haematologica. 2019 Mar;104(3):e97-e99. doi: 10.3324/haematol.2018.201194. Epub 2018 Sep 27. No abstract available.

23.

Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis.

Jachiet V, Lhote R, Rufat P, Pha M, Haroche J, Crozier S, Dupel-Potier C, Psimaras D, Amoura Z, Cohen Aubart F.

J Neurol. 2018 Oct;265(10):2333-2341. doi: 10.1007/s00415-018-9001-x. Epub 2018 Aug 14.

24.

Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients.

Mekinian A, Maisonobe L, Boukari L, Melenotte C, Terrier B, Ayrignac X, Schleinitz N, Sène D, Hamidou M, Konaté A, Guilpain P, Abisror N, Ghrenassia E, Lachenal F, Cevallos R, Roos-Weil R, Du LTH, Lhote F, Larroche C, Bergmann JF, Humbert S, Fraison JB, Piette JC, Guillevin L, Dhote R, Amoura Z, Haroche J, Fain O.

Medicine (Baltimore). 2018 Jul;97(30):e11413. doi: 10.1097/MD.0000000000011413. Erratum in: Medicine (Baltimore). 2018 Aug;97(33):e12063.

25.

Hypogonadism as a Reversible Cause of Torsades de Pointes in Men.

Salem JE, Waintraub X, Courtillot C, Shaffer CM, Gandjbakhch E, Maupain C, Moslehi JJ, Badilini F, Haroche J, Gougis P, Fressart V, Glazer AM, Hidden-Lucet F, Touraine P, Lebrun-Vignes B, Roden DM, Bachelot A, Funck-Brentano C.

Circulation. 2018 Jul 3;138(1):110-113. doi: 10.1161/CIRCULATIONAHA.118.034282. No abstract available.

26.

Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.

Cohen-Aubart F, Guerin M, Poupel L, Cluzel P, Saint-Charles F, Charlotte F, Arsafi Y, Emile JF, Frisdal E, Le Goff C, Donadieu J, Amoura Z, Lesnik P, Haroche J, Le Goff W.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1913-1925. doi: 10.1161/ATVBAHA.118.310803.

PMID:
29930009
27.

Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study.

Cohen Aubart F, Abbara S, Maisonobe T, Cottin V, Papo T, Haroche J, Mathian A, Pha M, Gilardin L, Hervier B, Soussan M, Morlat P, Nunes H, Benveniste O, Amoura Z, Valeyre D.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 16;5(3):e452. doi: 10.1212/NXI.0000000000000452. eCollection 2018 May.

28.

BRAF V600E mutation detected in a case of Rosai-Dorfman disease.

Fatobene G, Haroche J, Hélias-Rodzwicz Z, Charlotte F, Taly V, Ferreira AM, Abdo ANR, Rocha V, Emile JF.

Haematologica. 2018 Aug;103(8):e377-e379. doi: 10.3324/haematol.2018.190934. Epub 2018 May 10. No abstract available.

29.

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL.

Blood. 2018 Jun 28;131(26):2877-2890. doi: 10.1182/blood-2018-03-839753. Epub 2018 May 2. Review.

30.

More on Ofatumumab for TTP.

Cohen Aubart F, Haroche J, Amoura Z.

N Engl J Med. 2018 Apr 5;378(14):1364-5. doi: 10.1056/NEJMc1801263. No abstract available.

PMID:
29619817
31.

[Rosai-Dorfman disease: Diagnosis and therapeutic challenges].

Cohen Aubart F, Haroche J, Emile JF, Charlotte F, Barete S, Schleinitz N, Donadieu J, Amoura Z.

Rev Med Interne. 2018 Aug;39(8):635-640. doi: 10.1016/j.revmed.2018.02.011. Epub 2018 Mar 1. Review. French.

PMID:
29501513
32.

Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort.

Cohen-Aubart F, Emile JF, Carrat F, Helias-Rodzewicz Z, Taly V, Charlotte F, Cluzel P, Donadieu J, Idbaih A, Barete S, Amoura Z, Haroche J.

Am J Hematol. 2018 May;93(5):E114-E117. doi: 10.1002/ajh.25055. Epub 2018 Feb 10. No abstract available.

33.

Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study.

Couture P, Chazal T, Rosso C, Haroche J, Léger A, Hervier B, Deltour S, Amoura Z, Cohen Aubart F.

J Neurol. 2018 Apr;265(4):757-763. doi: 10.1007/s00415-018-8744-8. Epub 2018 Feb 1.

PMID:
29392458
34.

Efficacy of infliximab in the treatment of Erdheim-Chester disease.

Cohen-Aubart F, Maksud P, Emile JF, Benameur N, Charlotte F, Cluzel P, Amoura Z, Haroche J.

Ann Rheum Dis. 2018 Sep;77(9):1387-1390. doi: 10.1136/annrheumdis-2017-212678. Epub 2018 Jan 23. No abstract available.

PMID:
29363511
35.

Cutaneous manifestations of paediatric Erdheim-Chester disease, a histiocytosis of the 'L' group.

Chasset F, Haroche J.

Br J Dermatol. 2018 Jan;178(1):31-32. doi: 10.1111/bjd.15860. No abstract available.

PMID:
29357606
36.

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease.

Danlos FX, Voisin AL, Dyevre V, Michot JM, Routier E, Taillade L, Champiat S, Aspeslagh S, Haroche J, Albiges L, Massard C, Girard N, Dalle S, Besse B, Laghouati S, Soria JC, Mateus C, Robert C, Lanoy E, Marabelle A, Lambotte O.

Eur J Cancer. 2018 Mar;91:21-29. doi: 10.1016/j.ejca.2017.12.008. Epub 2018 Jan 10.

PMID:
29331748
37.

Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases.

de Risi-Pugliese T, Cohen Aubart F, Haroche J, Moguelet P, Grootenboer-Mignot S, Mathian A, Ingen-Housz-Oro S, Hie M, Wendremaire N, Aucouturier F, Lepelletier F, Miyara M, Bader-Meunier B, Rémy P, Fabien N, Francès C, Barete S, Amoura Z.

Semin Arthritis Rheum. 2018 Aug;48(1):83-89. doi: 10.1016/j.semarthrit.2017.11.003. Epub 2017 Nov 4.

PMID:
29191376
38.

Neurodegeneration in histiocytoses might start in utero.

Haroche J, Cohen-Aubart F, Emile JF, Donadieu J, Amoura Z.

Lancet Neurol. 2017 Dec;16(12):953-954. doi: 10.1016/S1474-4422(17)30373-3. Epub 2017 Oct 27. No abstract available.

PMID:
29111143
39.

Cerebral pseudo-tumoral neuro-Behcet: Histological demonstration of an inflammatory and vascular disease.

Cohen-Aubart F, Psimaras D, Galanaud D, Bielle F, Touitou V, Haroche J, Amoura Z.

Clin Neurol Neurosurg. 2017 Oct;161:48-50. doi: 10.1016/j.clineuro.2017.08.004. Epub 2017 Aug 12. No abstract available.

PMID:
28843707
40.

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

Papo M, Diamond EL, Cohen-Aubart F, Emile JF, Roos-Weil D, Gupta N, Durham BH, Ozkaya N, Dogan A, Ulaner GA, Rampal R, Kahn JE, Sené T, Charlotte F, Hervier B, Besnard C, Bernard OA, Settegrana C, Droin N, Hélias-Rodzewicz Z, Amoura Z, Abdel-Wahab O, Haroche J.

Blood. 2017 Aug 24;130(8):1007-1013. doi: 10.1182/blood-2017-01-761718. Epub 2017 Jul 5.

41.

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).

Cohen Aubart F, Emile JF, Carrat F, Charlotte F, Benameur N, Donadieu J, Maksud P, Idbaih A, Barete S, Hoang-Xuan K, Amoura Z, Haroche J.

Blood. 2017 Sep 14;130(11):1377-1380. doi: 10.1182/blood-2017-03-771873. Epub 2017 Jun 30. No abstract available.

PMID:
28667012
42.

A causality algorithm to guide diagnosis and treatment of catatonia due to autoimmune conditions in children and adolescents.

Ferrafiat V, Raffin M, Freri E, Granata T, Nardocci N, Zibordi F, Bodeau N, Benarous X, Olliac B, Riquin E, Xavier J, Viaux S, Haroche J, Amoura Z, Gerardin P, Cohen D, Consoli A.

Schizophr Res. 2018 Oct;200:68-76. doi: 10.1016/j.schres.2017.06.036. Epub 2017 Jun 26.

PMID:
28659239
43.

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells.

Durham BH, Roos-Weil D, Baillou C, Cohen-Aubart F, Yoshimi A, Miyara M, Papo M, Hélias-Rodzewicz Z, Terrones N, Ozkaya N, Dogan A, Rampal R, Urbain F, Le Fèvre L, Diamond EL, Park CY, Papo T, Charlotte F, Gorochov G, Taly V, Bernard OA, Amoura Z, Abdel-Wahab O, Lemoine FM, Haroche J, Emile JF.

Blood. 2017 Jul 13;130(2):176-180. doi: 10.1182/blood-2016-12-757377. Epub 2017 May 31.

44.

Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study.

Rivière E, Cohen Aubart F, Maisonobe T, Maurier F, Richez C, Gombert B, Gousseff M, Adoue D, Mathian A, Hié M, Haroche J, Amoura Z.

J Neurol. 2017 Jun;264(6):1218-1226. doi: 10.1007/s00415-017-8519-7. Epub 2017 May 23.

PMID:
28536920
45.

Cerebrovascular events are associated with lower survival in giant cell arteritis: A case-controlled multicenter study.

Chazal T, Couture P, Rosso C, Haroche J, Léger A, Hervier B, Deltour S, Rufat P, Amoura Z, Cohen Aubart F.

Joint Bone Spine. 2018 May;85(3):383-385. doi: 10.1016/j.jbspin.2017.05.017. Epub 2017 May 19. No abstract available.

PMID:
28532822
46.

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.

Tazi A, Lorillon G, Haroche J, Neel A, Dominique S, Aouba A, Bouaziz JD, de Margerie-Melon C, Bugnet E, Cottin V, Comont T, Lavigne C, Kahn JE, Donadieu J, Chevret S.

Orphanet J Rare Dis. 2017 May 22;12(1):95. doi: 10.1186/s13023-017-0651-z.

47.

Endocrine perturbations in POEMS syndrome: Misunderstood features of a rare paraneoplastic syndrome.

Marchand M, Haroche J, Touraine P, Courtillot C.

Ann Endocrinol (Paris). 2017 Jul;78(3):190-194. doi: 10.1016/j.ando.2017.01.004. Epub 2017 May 8. Review. No abstract available.

PMID:
28495325
48.

Long-term outcomes of refractory neurosarcoidosis treated with infliximab.

Cohen Aubart F, Bouvry D, Galanaud D, Dehais C, Mathey G, Psimaras D, Haroche J, Pottier C, Hie M, Mathian A, Devilliers H, Nunes H, Valeyre D, Amoura Z.

J Neurol. 2017 May;264(5):891-897. doi: 10.1007/s00415-017-8444-9. Epub 2017 Mar 4.

PMID:
28260120
49.

Histiocytoses: emerging neoplasia behind inflammation.

Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte F, Idbaih A, Vaglio A, Abdel-Wahab O, Emile JF, Amoura Z.

Lancet Oncol. 2017 Feb;18(2):e113-e125. doi: 10.1016/S1470-2045(17)30031-1. Review.

PMID:
28214412
50.

[Sarcoidosis flare after autologous stem cell transplantation: An immune paradox?]

Marchal A, Charlotte F, Maksud P, Haroche J, Lifferman F, Miyara M, Choquet S, Amoura Z, Cohen Aubart F.

Rev Med Interne. 2017 Sep;38(9):619-622. doi: 10.1016/j.revmed.2017.01.001. Epub 2017 Feb 10. French.

PMID:
28196699

Supplemental Content

Loading ...
Support Center